References
- de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Hum Reprod 2009;24:425-8 [PubMed: 18948313]
- Lewis T, Goldstein I. Transfer of topical testosterone preparations to children or spouses. J Sex Med 2009;6:2649-52
- Stahlman J, Britto M, Fitzpatrick S, et al. Effect of application site, clothing barrier and application site washing on testosterone transfer with a 1.62% testosterone gel. Curr Med Res Opin 2012;28: 281-90
- Stahlman J, Britto M, Fitzpatrick S, et al. Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption. Curr Med Res Opin 2012;28: 291-301
- Stahlman J, Britto M, Fitzpatrick S, et al. The effects of skin washing on the systemic absorption of testosterone in hypogonadal males after administration of a 1.62% testosterone gel. Curr Med Res Opin 2012;28: 271-9
- Axiron (testosterone) topical solution [prescribing information]. Indianapolis, IN: Lilly USA, LLC, 2010
- Testim 1% (testosterone gel) [prescribing information]. Malvern, PA, USA: Auxilium Pharmaceuticals, Inc., 2009
- AndroGel (testosterone gel) 1% [prescribing information]. North Chicago, IL, USA: Abbott Laboratories, 2010
- Fortesta (testosterone gel) [prescribing information]. Chadds Ford, PA, USA: Endo Pharmaceuticals Inc., 2010
- AndroGel (testosterone gel) 1.62% [prescribing information]. North Chicago, IL, USA: Abbott Laboratories, 2011
- Rolf C, Knie U, Lemmnitz G, et al. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol (Oxf) 2002;56:637-41 [PubMed: 12030915]
- Briefing information for the June 23, 2009 meeting of the Pediatric Advisory Committee. Silver Spring, MD, USA: US Food and Drug Administration, 2009 US Food and Drug Administration [accessed Jan 4 2012]. Available at: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ucm116530.htm
- Cavender RK, Fairall M. Precocious puberty secondary to topical testosterone transfer: a case report. J Sex Med 2011;8:622-6 [PubMed: 21114766]
- Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old-boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila) 2007;46:540-3 [PubMed: 17579107]
- Kunz GJ, Klein KO, Clemons RD, et al. Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114:282-4 [PubMed:15231947]
- Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007;87:976.e13-15 [PubMed: 17254577]
- Testosterone gel safety concerns prompt FDA to require label changes, medication guide (FDA news release). US Food and Drug Administration, 2009 US Food and Drug Administration [Accessed Jan 4 2012]. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149580.htm
- Medication Guide AndroGel CIII (testosterone gel) 1.62%. North Chicago, IL, USA: Abbott Laboratories, 2011 [Accessed Jan 4 2012]. Available at: http://rxabbott.com/pdf/androgel1_62_medguide.pdf
- Busse KL, Maibach HI. Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention. Skin Pharmacol Physiol 2011;24:57-66 [PubMed: 21088452]
- Mazer N, Fisher D, Fischer J, et al. Transfer of transdermally applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel. J Sex Med 2005;2:227-34 [PubMed: 16422890]
- de Ronde W, Vogel S, Bui HN, et al. Reduction in 24-hour plasma testosterone levels in subjects who showered 15 or 30 minutes after application of testosterone gel. Pharmacotherapy 2011;31:248-52 [PubMed: 21361734]
- Zumoff B, Bradlow HL, Finkelstein J, et al. The influence of age and sex on the metabolism of testosterone. J Clin Endocrinol Metab 1976;42:703-6 [PubMed: 1262444]